NeuroOne® Announces Breakthrough Case Completed with OneRF™ Ablation System at the University Hospitals in Cleveland Forty-four ablations performed successfully in one patient Patient currently reportedly seizure free with improvements in mood and memory EDEN PRAIRIE, Minn., Sept. 10, 2024 (GLOBE NEWSWIRE)...

NeuroOne® Announces First in Human Ablations Completed with OneRF™ Ablation System Five ablations performed successfully in one patient Procedure performed at patient’s bedside saving time and cost associated with the operating room EDEN PRAIRIE, Minn., June 25, 2024 (GLOBE...

NeuroOne® Receives FDA 510(k) Clearance to Market its OneRF™ Ablation System First FDA-cleared thin-film, sEEG-guided RF system capable of both recording electrical activity and ablating nervous tissue with the added benefit of temperature control; Marks the Company’s third...

NeuroOne Medical Technologies Corporation Announces Pricing of Public Offering of Common Stock EDEN PRAIRIE, Minn., July 25, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (the “Company”), a medical technology company focused on improving surgical care...